These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 21440957)
1. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer]. Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957 [No Abstract] [Full Text] [Related]
2. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975 [TBL] [Abstract][Full Text] [Related]
3. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws. Oreadi D; Papageorge MB J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801 [No Abstract] [Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion. Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015 [No Abstract] [Full Text] [Related]
5. [Bisphosphonates-induced osteonecrosis of the jaw: CT-findings]. Maksimovic O; Denecke B; Pintoffl JP; Horger M Rofo; 2008 Apr; 180(4):277-9. PubMed ID: 18432565 [No Abstract] [Full Text] [Related]
6. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R; Lo Muzio L J Clin Oncol; 2006 Mar; 24(9):1475-7. PubMed ID: 16549843 [No Abstract] [Full Text] [Related]
7. Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. Frei M; Bornstein MM; Schaller B; Reichart PA; Weimann R; Iizuka T J Oral Maxillofac Surg; 2010 Apr; 68(4):863-7. PubMed ID: 20307770 [No Abstract] [Full Text] [Related]
8. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates. Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013 [TBL] [Abstract][Full Text] [Related]
10. Radiology quiz case. Osteonecrosis of the jaw: aminobisphosphonate epidemic. Junquera L; Gallego L; Villarreal P Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1229-31. PubMed ID: 19015457 [No Abstract] [Full Text] [Related]
11. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw? Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255 [TBL] [Abstract][Full Text] [Related]
12. A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer. Goldman ML; Denduluri N; Berman AW; Sausville R; Guadagnini JP; Kleiner DE; Brahim JS; Swain SM Oncology; 2006; 71(3-4):306-8. PubMed ID: 17657174 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaw and left thumb. Longo R; Castellana MA; Gasparini G J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386 [No Abstract] [Full Text] [Related]
14. Avascular osteonecrosis of the mandible following bisphosphonate therapy. Chandra PA; Chandra AB; Todd GK Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056 [TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib. Bozas G; Roy A; Ramasamy V; Maraveyas A Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: similarities with phossy jaw. Campisi G; Compilato D; Angelo I; Lo Muzio L; Colella G Indian J Dent Res; 2012; 23(5):683-5. PubMed ID: 23422621 [TBL] [Abstract][Full Text] [Related]
17. Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma. Smidt-Hansen T; Folkmar TB; Fode K; Agerbaek M; Donskov F J Oral Maxillofac Surg; 2013 Sep; 71(9):1532-40. PubMed ID: 23642545 [TBL] [Abstract][Full Text] [Related]
19. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years. Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374 [TBL] [Abstract][Full Text] [Related]
20. Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws. Herbozo PJ; Briones DL; Ferres AJ; Torrealba RL J Oral Maxillofac Surg; 2007 Aug; 65(8):1650-4. PubMed ID: 17656297 [No Abstract] [Full Text] [Related] [Next] [New Search]